HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Supplemental table and figures All Versions of this Article: 16/3/361    most recent 00080.2003v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in ISI Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via ISI Web of Science (51) Citing Articles via Google Scholar Google Scholar Articles by Mah, N. Articles by Schreiber, S. Search for Related Content PubMed PubMed Citation Articles by Mah, N. Articles by Schreiber, S.

Toolbox

A comparison of oligonucleotide and cDNA-based microarray systems

¹ First Department of Medicine, Christian-Albrechts-University Kiel, D-24105 Kiel, Germany
² AstraZeneca R&D Mölndal, S-43183 Mölndal, Sweden
³ Department of Pathology, Christian-Albrechts-University Kiel, D-24105 Kiel, Germany
⁴ Max-Planck Institute for Molecular Genetics, D-14195 Berlin, Germany

Large-scale public data mining will become more common as public release of microarray data sets becomes a corequisite for publication. Therefore, there is an urgent need to clarify whether data from different microarray platforms are comparable. To assess the compatibility of microarray data, results were compared from the two main types of high-throughput microarray expression technologies, namely, an oligonucleotide-based and a cDNA-based platform, using RNA obtained from complex tissue (human colonic mucosa) of five individuals. From 715 sequence-verified genes represented on both platforms, 64% of the genes matched in "present" or "absent" calls made by both platforms. Calls were influenced by spurious signals caused by Alu repeats in cDNA clones, clone annotation errors, or matched probes that were designed to different regions of the gene; however, these factors could not completely account for the level of call discordance observed. Expression levels in sequence-verified, platform-overlapping genes were not related, as demonstrated by weakly positive rank order correlation. This study demonstrates that there is only moderate overlap in the results from the two array systems. This fact should be carefully considered when performing large-scale analyses on data originating from different microarray platforms.

noncommercial clone-based microarray system; commercial oligonucleotide-based microarray system; expression screening platform; cross-platform screening

This article has been cited by other articles:

				O. Emanuelsson, U. Nagalakshmi, D. Zheng, J. S. Rozowsky, A. E. Urban, J. Du, Z. Lian, V. Stolc, S. Weissman, M. Snyder, et al. Assessing the performance of different high-density tiling microarray strategies for mapping transcribed regions of the human genome Genome Res., June 1, 2007; 17(6): 886 - 897. [Abstract] [Full Text] [PDF]

				C. Andreadis, P. A. Gimotty, P. Wahl, R. Hammond, J. Houldsworth, S. J. Schuster, and T. R. Rebbeck Members of the glutathione and ABC-transporter families are associated with clinical outcome in patients with diffuse large B-cell lymphoma Blood, April 15, 2007; 109(8): 3409 - 3416. [Abstract] [Full Text] [PDF]

				A. S. Siddiqui, A. D. Delaney, A. Schnerch, O. L. Griffith, S. J. M. Jones, and M. A. Marra Sequence biases in large scale gene expression profiling data Nucleic Acids Res., July 13, 2006; 34(12): e83 - e83. [Abstract] [Full Text] [PDF]

				M. J. Hessner, B. Xiang, S. Jia, R. Geoffrey, S. Holmes, L. Meyer, S. Muheisen, and X. Wang Three-color cDNA microarrays with prehybridization quality control yield gene expression data comparable to that of commercial platforms Physiol Genomics, March 13, 2006; 25(1): 166 - 178. [Abstract] [Full Text] [PDF]

				S. J. Ott, N. E. El Mokhtari, M. Musfeldt, S. Hellmig, S. Freitag, A. Rehman, T. Kuhbacher, S. Nikolaus, P. Namsolleck, M. Blaut, et al. Detection of Diverse Bacterial Signatures in Atherosclerotic Lesions of Patients With Coronary Heart Disease Circulation, February 21, 2006; 113(7): 929 - 937. [Abstract] [Full Text] [PDF]

				D. R. Boverhof and T. R. Zacharewski Toxicogenomics in Risk Assessment: Applications and Needs Toxicol. Sci., February 1, 2006; 89(2): 352 - 360. [Abstract] [Full Text] [PDF]

				L. Xu, A. C. Tan, D. Q. Naiman, D. Geman, and R. L. Winslow Robust prostate cancer marker genes emerge from direct integration of inter-study microarray data Bioinformatics, October 15, 2005; 21(20): 3905 - 3911. [Abstract] [Full Text] [PDF]

				M. Fluck, C. Dapp, S. Schmutz, E. Wit, and H. Hoppeler Transcriptional profiling of tissue plasticity: role of shifts in gene expression and technical limitations J Appl Physiol, August 1, 2005; 99(2): 397 - 413. [Abstract] [Full Text] [PDF]

				C. L. Yauk, M. L. Berndt, A. Williams, and G. R. Douglas Comprehensive comparison of six microarray technologies Nucleic Acids Res., August 27, 2004; 32(15): e124 - e124. [Abstract] [Full Text] [PDF]